{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:27:22Z","timestamp":1787927242253,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiangsu Provincial Research Hospital","award":["YJXYY202204"],"award-info":[{"award-number":["YJXYY202204"]}]},{"DOI":"10.13039\/501100018557","name":"Science and technology Project of Nantong City","doi-asserted-by":"crossref","award":["XNBH00031655"],"award-info":[{"award-number":["XNBH00031655"]}],"id":[{"id":"10.13039\/501100018557","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Provincial Medical Key Discipline Cultivation Unit","award":["JSDW202205"],"award-info":[{"award-number":["JSDW202205"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["BK20241838"],"award-info":[{"award-number":["BK20241838"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82502178"],"award-info":[{"award-number":["82502178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10787-026-02321-3","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T04:39:48Z","timestamp":1783312788000},"page":"5565-5576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Agomelatine for Sj\u00f6gren\u2019s syndrome: a study on its therapeutic effects and mechanisms"],"prefix":"10.1007","volume":"34","author":[{"given":"Xiaoxiao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nengjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"2321_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuint.2018.09.006","volume":"120","author":"SF Ahmad","year":"2018","unstructured":"Ahmad SF, Nadeem A, Ansari MA, Bakheet SA, Alshammari MA, Attia SM (2018a) The PPARdelta agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17\/Treg-related signaling in the BTBR autistic mouse model. Neurochem Int 120:251\u2013261","journal-title":"Neurochem Int"},{"key":"2321_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.pnpbp.2017.10.001","volume":"81","author":"SF Ahmad","year":"2018","unstructured":"Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, Attia SM (2018b) Upregulation of peripheral CXC and CC chemokine receptor expression on CD4(+) T cells is associated with immune dysregulation in children with autism. Prog Neuropsychopharmacol Biol Psychiatry 81:211\u2013220","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2321_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cellsig.2018.09.006","volume":"52","author":"SF Ahmad","year":"2018","unstructured":"Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alshammari MA, Khan MR, Alsaad AMS, Attia SM (2018c) S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T(+) Itpr3(tf)\/J mice. Cell Signal 52:127\u2013136","journal-title":"Cell Signal"},{"key":"2321_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2020.172859","volume":"189","author":"SF Ahmad","year":"2020","unstructured":"Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alqahtani F, Alhoshani AR, Alasmari F, Alsaleh NB, Attia SM (2020) 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T(+) Itpr3(tf)\/J mouse model for autism. Pharmacol Biochem Behav 189:172859","journal-title":"Pharmacol Biochem Behav"},{"key":"2321_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.995895","volume":"13","author":"Q An","year":"2022","unstructured":"An Q, Zhao J, Zhu X, Yang B, Wu Z, Su Y, Zhang L, Xu K, Ma D (2022) Exploiting the role of T cells in the pathogenesis of Sjogren\u2019s syndrome for therapeutic treatment. Front Immunol 13:995895","journal-title":"Front Immunol"},{"key":"2321_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106494","volume":"84","author":"SA Bakheet","year":"2020","unstructured":"Bakheet SA, Alrwashied BS, Ansari MA, Nadeem A, Attia SM, Assiri MA, Alqahtani F, Ibrahim KE, Ahmad SF (2020) CXCR3 antagonist AMG487 inhibits glucocorticoid-induced tumor necrosis factor-receptor-related protein and inflammatory mediators in CD45 expressing cells in collagen-induced arthritis mouse model. Int Immunopharmacol 84:106494","journal-title":"Int Immunopharmacol"},{"key":"2321_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","volume":"20","author":"C Baldini","year":"2024","unstructured":"Baldini C, Fulvio G, la Rocca G, Ferro F (2024) Update on the pathophysiology and treatment of primary Sjogren syndrome. Nat Rev Rheumatol 20:473\u2013491","journal-title":"Nat Rev Rheumatol"},{"key":"2321_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/JCP.0b013e31829057ae","volume":"33","author":"A Bruno","year":"2013","unstructured":"Bruno A, Mico U, Lorusso S, Cogliandro N, Pandolfo G, Caminiti M, Zoccali RA, Muscatello MR (2013) Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study. J Clin Psychopharmacol 33:507\u2013511","journal-title":"J Clin Psychopharmacol"},{"key":"2321_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2023.05.027","volume":"205","author":"T Cao","year":"2023","unstructured":"Cao T, Zhou J, Liu Q, Mao T, Chen B, Wu Q, Wang L, Pathak JL, Watanabe N, Li J (2023) Interferon-gamma induces salivary gland epithelial cell ferroptosis in Sjogren\u2019s syndrome via JAK\/STAT1-mediated inhibition of system Xc(). Free Radic Biol Med 205:116\u2013128","journal-title":"Free Radic Biol Med"},{"key":"2321_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103268","volume":"22","author":"C Chivasso","year":"2023","unstructured":"Chivasso C, D\u2019Agostino C, Parisis D, Soyfoo MS, Delporte C (2023) Involvement of aquaporin 5 in Sjogren\u2019s syndrome. Autoimmun Rev 22:103268","journal-title":"Autoimmun Rev"},{"key":"2321_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103756","volume":"24","author":"ACM Costa","year":"2025","unstructured":"Costa ACM, Nunes DPF, Julio PR, Marchi-Silva R, De Aquino BM, De Oliveira Andrade S, Pereira DR, Mazzola TN, De Souza JM, Martinez ARM, Franca MC Jr, Reis F, Touma Z, Niewold TB, Appenzeller S (2025) Neuropsychiatric manifestations in systemic lupus erythematosus and Sjogren\u2019s disease. Autoimmun Rev 24:103756","journal-title":"Autoimmun Rev"},{"key":"2321_CR12","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2147\/PPA.S163417","volume":"12","author":"Y Cui","year":"2018","unstructured":"Cui Y, Li L, Xia L, Zhao Q, Chen S, Fu T, Ji J, Gu Z (2018a) The impact of disease activity and psychological status on quality of life for Chinese patients with primary Sjogren\u2019s syndrome. Patient Prefer Adherence 12:1513\u20131519","journal-title":"Patient Prefer Adherence"},{"key":"2321_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12888-018-1715-x","volume":"18","author":"Y Cui","year":"2018","unstructured":"Cui Y, Xia L, Li L, Zhao Q, Chen S, Gu Z (2018b) Anxiety and depression in primary Sjogren\u2019s syndrome: a cross-sectional study. BMC Psychiatry 18:131","journal-title":"BMC Psychiatry"},{"key":"2321_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102987","volume":"20","author":"R Goulabchand","year":"2021","unstructured":"Goulabchand R, Malafaye N, Jacot W, Viel PW, Morel J, Lukas C, Rozier P, Lamure S, No\u00ebl D, Molinari N, Mura T, Guilpain P (2021) Cancer incidence in primary Sjogren\u2019s syndrome: data from the French hospitalization database. Autoimmun Rev 20:102987","journal-title":"Autoimmun Rev"},{"key":"2321_CR15","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.1038\/s41598-022-17354-1","volume":"12","author":"R Goulabchand","year":"2022","unstructured":"Goulabchand R, Castille E, Navucet S, Etchecopar-Etchart D, Matos A, Maria A, Gutierrez LA, le Quellec A, de Champfleur NM, Gabelle A, Guilpain P (2022) The interplay between cognition, depression, anxiety, and sleep in primary Sjogren\u2019s syndrome patients. Sci Rep 12:13176","journal-title":"Sci Rep"},{"key":"2321_CR16","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/ard-2023-224842","volume":"83","author":"S Gupta","year":"2024","unstructured":"Gupta S, Yamada E, Nakamura H, Perez P, Pranzatelli TJ, Dominick K, Jang SI, Abed M, Martin D, Burbelo P, Zheng C, French B, Alevizos I, Khavandgar Z, Beach M, Pelayo E, Walitt B, Hasni S, Kaplan MJ, Tandon M, Magone MT, Kleiner DE, Chiorini JA, Baer A, Warner BM (2024) Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjogren\u2019s disease. Ann Rheum Dis 83:1034\u20131047","journal-title":"Ann Rheum Dis"},{"key":"2321_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111282","volume":"126","author":"P Hu","year":"2024","unstructured":"Hu P, Cai J, Yang C, Xu L, Ma S, Song H, Yang P (2024) SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1\/STAT3 pathway in primary Sjogren\u2019s syndrome. Int Immunopharmacol 126:111282","journal-title":"Int Immunopharmacol"},{"issue":"Suppl 118","key":"2321_CR18","first-page":"78","volume":"37","author":"I Lewis","year":"2019","unstructured":"Lewis I, Hackett KL, Ng WF, Ellis J, Newton JL (2019) A two-phase cohort study of the sleep phenotype within primary Sjogren\u2019s syndrome and its clinical correlates. Clin Exp Rheumatol 37(Suppl 118):78\u201382","journal-title":"Clin Exp Rheumatol"},{"key":"2321_CR19","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s10067-018-4233-9","volume":"37","author":"Z Li","year":"2018","unstructured":"Li Z, Fu T, Li L, Cui Y, Dong C, Li J, Gu Z (2018) Prevalence, severity, and predictors of dry eye and dry mouth in Chinese patients with primary Sjogren syndrome. Clin Rheumatol 37:2971\u20132979","journal-title":"Clin Rheumatol"},{"key":"2321_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.molimm.2024.02.012","volume":"169","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang F, Cheng B, Zhou G (2024) Melatonin improves salivary gland damage and hypofunction in pSS by inhibiting IL-6\/STAT3 signaling through its receptor-dependent manner. Mol Immunol 169:10\u201327","journal-title":"Mol Immunol"},{"key":"2321_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156525","volume":"139","author":"G Liu","year":"2025","unstructured":"Liu G, Wang J, Liu J, Chen Y, Wang Z, Chu T, Wu Y, Li Y, Shang E, Xu B, Fang W (2025) Total glucosides of paeony alleviates Sjogren\u2019s syndrome by inhibiting Th1 and Th17 responses. Phytomedicine 139:156525","journal-title":"Phytomedicine"},{"key":"2321_CR22","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2025.030701","volume":"35","author":"F Mrsi\u0107","year":"2025","unstructured":"Mrsi\u0107 F, Vukasovi\u0107 I, Te\u0161ija Kuna A, Ladika Davidovi\u0107 B, Markeljevi\u0107 J (2025) Association of inflammatory markers with depression and anxiety in female patients with primary Sjogren\u2019s syndrome. Biochem Med (Zagreb) 35:030701","journal-title":"Biochem Med (Zagreb)"},{"key":"2321_CR23","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.3390\/ijms19113548","volume":"19","author":"Y Ogawa","year":"2018","unstructured":"Ogawa Y, Shimizu E, Tsubota K (2018) Interferons and dry eye in Sjogren\u2019s syndrome. Int J Mol Sci 19:3548","journal-title":"Int J Mol Sci"},{"key":"2321_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zeron P, Bombardieri S, Bootsma H, De Vita S, Dorner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Siso-Almirall A, Tzioufas AG, Vitali C, Bowman S, Mariette X, Group EU-S S T F (2020) EULAR recommendations for the management of Sjogren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis 79:3\u201318","journal-title":"Ann Rheum Dis"},{"key":"2321_CR25","doi-asserted-by":"publisher","first-page":"eado4856","DOI":"10.1126\/scitranslmed.ado4856","volume":"16","author":"YH Wang","year":"2024","unstructured":"Wang YH, Li W, McDermott M, Son GY, Maiti G, Zhou F, Tao AY, Raphael D, Moreira AL, Shen B, Vaeth M, Nadorp B, Chakravarti S, Lacruz RS, Feske S (2024) IFN-gamma-producing T(H)1 cells and dysfunctional regulatory T cells contribute to the pathogenesis of Sjogren\u2019s disease. Sci Transl Med 16:eado4856","journal-title":"Sci Transl Med"},{"key":"2321_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00011-025-02047-y","volume":"74","author":"X Weng","year":"2025","unstructured":"Weng X, Wang S, Wang Q, Wei M, Cheng B (2025) Melatonin inhibits salivary gland epithelial cell ferroptosis via the NRF2\/HO-1\/GPX4 signaling pathway in primary Sjogren\u2019s syndrome. Inflamm Res 74:84","journal-title":"Inflamm Res"},{"key":"2321_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.974648","volume":"13","author":"X Xin","year":"2022","unstructured":"Xin X, Wang Q, Qing J, Song W, Gui Y, Li X, Li Y (2022) Th17 cells in primary Sjogren\u2019s syndrome negatively correlate with increased Roseburia and Coprococcus. Front Immunol 13:974648","journal-title":"Front Immunol"},{"key":"2321_CR28","doi-asserted-by":"publisher","first-page":"1127417","DOI":"10.3389\/fimmu.2023.1127417","volume":"14","author":"Q Zhan","year":"2023","unstructured":"Zhan Q, Zhang J, Lin Y, Chen W, Fan X, Zhang D (2023) Pathogenesis and treatment of Sjogren\u2019s syndrome: review and update. Front Immunol 14:1127417","journal-title":"Front Immunol"},{"key":"2321_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10067-019-04753-5","volume":"39","author":"R Zhao","year":"2020","unstructured":"Zhao R, Wang Y, Zhou W, Guo J, He M, Li P, Gao J, Gu Z, Dong C (2020) Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjogren\u2019s syndrome. Clin Rheumatol 39:483\u2013489","journal-title":"Clin Rheumatol"},{"key":"2321_CR30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10067-023-06853-9","volume":"43","author":"R Zhao","year":"2024","unstructured":"Zhao R, Dong C, Gu Z, Ding X, Li J (2024) Development and validation of a nomogram for predicting fatigue in patients with primary Sjogren\u2019s syndrome. Clin Rheumatol 43:717\u2013724","journal-title":"Clin Rheumatol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02321-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02321-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02321-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:46:59Z","timestamp":1787924819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02321-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2321"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02321-3","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}